Teva-Rosuvastatin 5 mg

Teva-Rosuvastatin 5 mg is a cholesterol-lowering medication designed to help manage high cholesterol levels. This oral tablet from Teva Canada Limited is commonly used to support cardiovascular health by reducing LDL cholesterol and triglycerides.

Rosuvastatin, the active ingredient in Teva-Rosuvastatin, is primarily used to lower cholesterol levels in the blood. It is often prescribed for individuals with high cholesterol or those at risk of cardiovascular diseases. Rosuvastatin works by inhibiting an enzyme in the liver that produces cholesterol, thereby reducing the amount of cholesterol circulating in the bloodstream. This medication is part of a broader strategy that includes diet and exercise to manage cholesterol levels effectively.

Common effects of Rosuvastatin may include muscle pain, headaches, and digestive issues. Some individuals might experience mild to moderate side effects such as nausea, dizziness, or fatigue. These effects are generally temporary and may subside as the body adjusts to the medication. However, persistent or severe side effects should be discussed with a healthcare provider.

Rosuvastatin should be handled with care, especially by individuals with certain medical conditions such as liver disease or kidney problems. It is important to follow the prescribed dosage and to inform healthcare providers about any other medications being taken. Regular monitoring of liver function may be recommended during treatment. Pregnant women or those planning to become pregnant should consult their healthcare provider before using this medication.

Rosuvastatin may interact with certain medications, including some antibiotics, antifungal drugs, and other cholesterol-lowering agents. Alcohol consumption should be moderated, as it can increase the risk of side effects. It is also advisable to avoid grapefruit and grapefruit juice, as they can affect the metabolism of Rosuvastatin. Always inform healthcare providers about all medications and supplements being taken to avoid potential interactions.